Bharat Rasayan Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: July 3, 2025, 1:24 pm

Competitors of Bharat Rasayan Ltd

All Competitor Stocks of Bharat Rasayan Ltd

Quarterly Result

Last Updated: May 31, 2025, 9:38 am

Below is a detailed analysis of the quarterly data for Bharat Rasayan Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 307.00 Cr.. The value appears strong and on an upward trend. It has increased from 256.00 Cr. (Dec 2024) to 307.00 Cr., marking an increase of 51.00 Cr..
• For Expenses, as of Mar 2025, the value is 270.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 215.00 Cr. (Dec 2024) to 270.00 Cr., marking an increase of 55.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 37.00 Cr.. The value appears to be declining and may need further review. It has decreased from 42.00 Cr. (Dec 2024) to 37.00 Cr., marking a decrease of 5.00 Cr..
• For OPM %, as of Mar 2025, the value is 12.00%. The value appears to be declining and may need further review. It has decreased from 16.00% (Dec 2024) to 12.00%, marking a decrease of 4.00%.
• For Other Income, as of Mar 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 18.00 Cr. (Dec 2024) to 6.00 Cr., marking a decrease of 12.00 Cr..
• For Interest, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 1.00 Cr..
• For Depreciation, as of Mar 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 7.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 35.00 Cr.. The value appears to be declining and may need further review. It has decreased from 52.00 Cr. (Dec 2024) to 35.00 Cr., marking a decrease of 17.00 Cr..
• For Tax %, as of Mar 2025, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from 21.00% (Dec 2024) to 27.00%, marking an increase of 6.00%.
• For Net Profit, as of Mar 2025, the value is 25.00 Cr.. The value appears to be declining and may need further review. It has decreased from 41.00 Cr. (Dec 2024) to 25.00 Cr., marking a decrease of 16.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 60.48. The value appears to be declining and may need further review. It has decreased from 97.54 (Dec 2024) to 60.48, marking a decrease of 37.06.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 5:56 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 12:22 pm

Below is a detailed analysis of the balance sheet data for Bharat Rasayan Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 4.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,126.00 Cr.. The value appears strong and on an upward trend. It has increased from 984.00 Cr. (Mar 2024) to 1,126.00 Cr., marking an increase of 142.00 Cr..
• For Borrowings, as of Mar 2025, the value is 85.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 80.00 Cr. (Mar 2024) to 85.00 Cr., marking an increase of 5.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 193.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 129.00 Cr. (Mar 2024) to 193.00 Cr., marking an increase of 64.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,408.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,197.00 Cr. (Mar 2024) to 1,408.00 Cr., marking an increase of 211.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 230.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 230.00 Cr..
• For CWIP, as of Mar 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Mar 2024) to 15.00 Cr., marking an increase of 9.00 Cr..
• For Investments, as of Mar 2025, the value is 298.00 Cr.. The value appears strong and on an upward trend. It has increased from 143.00 Cr. (Mar 2024) to 298.00 Cr., marking an increase of 155.00 Cr..
• For Other Assets, as of Mar 2025, the value is 865.00 Cr.. The value appears strong and on an upward trend. It has increased from 818.00 Cr. (Mar 2024) to 865.00 Cr., marking an increase of 47.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,408.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,197.00 Cr. (Mar 2024) to 1,408.00 Cr., marking an increase of 211.00 Cr..

Notably, the Reserves (1,126.00 Cr.) exceed the Borrowings (85.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Bharat Rasayan Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 229.86. This value is within the healthy range. It has decreased from 299.89 (Mar 23) to 229.86, marking a decrease of 70.03.
• For Diluted EPS (Rs.), as of Mar 24, the value is 229.86. This value is within the healthy range. It has decreased from 299.89 (Mar 23) to 229.86, marking a decrease of 70.03.
• For Cash EPS (Rs.), as of Mar 24, the value is 258.47. This value is within the healthy range. It has decreased from 377.50 (Mar 23) to 258.47, marking a decrease of 119.03.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 2,377.47. It has increased from 2,149.86 (Mar 23) to 2,377.47, marking an increase of 227.61.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 2,377.47. It has increased from 2,149.86 (Mar 23) to 2,377.47, marking an increase of 227.61.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 2,514.03. It has decreased from 2,970.60 (Mar 23) to 2,514.03, marking a decrease of 456.57.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 332.52. This value is within the healthy range. It has decreased from 521.37 (Mar 23) to 332.52, marking a decrease of 188.85.
• For PBIT / Share (Rs.), as of Mar 24, the value is 270.46. This value is within the healthy range. It has decreased from 458.73 (Mar 23) to 270.46, marking a decrease of 188.27.
• For PBT / Share (Rs.), as of Mar 24, the value is 263.33. This value is within the healthy range. It has decreased from 433.75 (Mar 23) to 263.33, marking a decrease of 170.42.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 196.40. This value is within the healthy range. It has decreased from 314.86 (Mar 23) to 196.40, marking a decrease of 118.46.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 229.86. This value is within the healthy range. It has decreased from 299.89 (Mar 23) to 229.86, marking a decrease of 70.03.
• For PBDIT Margin (%), as of Mar 24, the value is 13.22. This value is within the healthy range. It has decreased from 17.55 (Mar 23) to 13.22, marking a decrease of 4.33.
• For PBIT Margin (%), as of Mar 24, the value is 10.75. This value is within the healthy range. It has decreased from 15.44 (Mar 23) to 10.75, marking a decrease of 4.69.
• For PBT Margin (%), as of Mar 24, the value is 10.47. This value is within the healthy range. It has decreased from 14.60 (Mar 23) to 10.47, marking a decrease of 4.13.
• For Net Profit Margin (%), as of Mar 24, the value is 7.81. This value is within the healthy range. It has decreased from 10.59 (Mar 23) to 7.81, marking a decrease of 2.78.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 9.14. This value is within the healthy range. It has decreased from 10.09 (Mar 23) to 9.14, marking a decrease of 0.95.
• For Return on Networth / Equity (%), as of Mar 24, the value is 9.66. This value is below the healthy minimum of 15. It has decreased from 13.94 (Mar 23) to 9.66, marking a decrease of 4.28.
• For Return on Capital Employeed (%), as of Mar 24, the value is 11.23. This value is within the healthy range. It has decreased from 21.10 (Mar 23) to 11.23, marking a decrease of 9.87.
• For Return On Assets (%), as of Mar 24, the value is 7.97. This value is within the healthy range. It has decreased from 11.60 (Mar 23) to 7.97, marking a decrease of 3.63.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.08. This value is within the healthy range. It has increased from 0.03 (Mar 23) to 0.08, marking an increase of 0.05.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.91. It has decreased from 1.14 (Mar 23) to 0.91, marking a decrease of 0.23.
• For Current Ratio (X), as of Mar 24, the value is 4.60. This value exceeds the healthy maximum of 3. It has decreased from 4.64 (Mar 23) to 4.60, marking a decrease of 0.04.
• For Quick Ratio (X), as of Mar 24, the value is 3.25. This value exceeds the healthy maximum of 2. It has increased from 2.74 (Mar 23) to 3.25, marking an increase of 0.51.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.30. This value is below the healthy minimum of 4. It has decreased from 2.85 (Mar 23) to 2.30, marking a decrease of 0.55.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 0.50 (Mar 23) to 0.00, marking a decrease of 0.50.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 0.41 (Mar 23) to 0.00, marking a decrease of 0.41.
• For Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 99.50 (Mar 23) to 0.00, marking a decrease of 99.50.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 99.59 (Mar 23) to 0.00, marking a decrease of 99.59.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 46.68. This value is within the healthy range. It has increased from 37.31 (Mar 23) to 46.68, marking an increase of 9.37.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 28.57. This value is within the healthy range. It has increased from 24.32 (Mar 23) to 28.57, marking an increase of 4.25.
• For Enterprise Value (Cr.), as of Mar 24, the value is 3,562.69. It has decreased from 3,772.42 (Mar 23) to 3,562.69, marking a decrease of 209.73.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 3.41. This value exceeds the healthy maximum of 3. It has increased from 3.06 (Mar 23) to 3.41, marking an increase of 0.35.
• For EV / EBITDA (X), as of Mar 24, the value is 25.78. This value exceeds the healthy maximum of 15. It has increased from 17.41 (Mar 23) to 25.78, marking an increase of 8.37.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 3.38. This value exceeds the healthy maximum of 3. It has increased from 3.06 (Mar 23) to 3.38, marking an increase of 0.32.
• For Retention Ratios (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 99.49 (Mar 23) to 0.00, marking a decrease of 99.49.
• For Price / BV (X), as of Mar 24, the value is 3.57. This value exceeds the healthy maximum of 3. It has decreased from 4.23 (Mar 23) to 3.57, marking a decrease of 0.66.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 3.38. This value exceeds the healthy maximum of 3. It has increased from 3.06 (Mar 23) to 3.38, marking an increase of 0.32.
• For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 23) to 0.02, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness